Search Results
Clinical Experience With PCSK9 Inhibitors
Mayo Clinic Experts Advise Caution with New Cholesterol Drugs- PCSK-9 Inhibitors
Pharmaceutical Economics and LDL-C Management: Implications PCSK9 Inhibitors in Clinical Practice
ACC.18 | ODYSSEY Outcomes
Luis Masana Marín, EASD 2019: PCSK9 Inhibition in Clinical Practice
ESC TV at ACC.17 - FOURIER Trial
Dr Steven Nissen on Which Patients Should Be Treated With PCSK9 Inhibitors
PCSK9 Inhibitors and CV Risk
#23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain
The ODYSSEY Outcomes Trial in CVD
Will PCSK9 Inhibitors Render PCI Obsolete? - Gregory Schwartz, MD
Does PCSK9 inhibition impact atherosclerosis? | Professor Steve Nicholls
